Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc (AMLN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Amylin Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. The reporting company's CIK number is 881464.
Total stock buying since 2005: $166,931,228.
Total stock sales since 2005: $345,918,013.
Total stock option exercises since 2005: $11,112,250.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-07 | 0 | $0 | 0 | $0 | 56,300 | $672,785 |
| 2012-05 | 0 | $0 | 0 | $0 | 18,000 | $167,040 |
| 2012-03 | 0 | $0 | 20,616 | $405,007 | 5,000 | $45,100 |
| 2012-02 | 0 | $0 | 63,142 | $1,067,438 | 0 | $0 |
| 2012-01 | 0 | $0 | 1,832 | $21,232 | 5,993 | $0 |
| 2011-10 | 0 | $0 | 15,000 | $131,220 | 62,500 | $358,125 |
| 2011-05 | 0 | $0 | 0 | $0 | 3,000 | $33,090 |
| 2011-03 | 0 | $0 | 13,750 | $206,525 | 13,750 | $128,246 |
| 2011-02 | 0 | $0 | 12,500 | $202,035 | 12,500 | $139,060 |
| 2011-01 | 0 | $0 | 3,170 | $47,509 | 2,500 | $27,812 |
| 2010-11 | 0 | $0 | 1,314 | $17,633 | 25,000 | $278,125 |
| 2010-05 | 0 | $0 | 0 | $0 | 10,000 | $102,500 |
| 2010-04 | 0 | $0 | 0 | $0 | 638 | $8,453 |
| 2010-03 | 0 | $0 | 0 | $0 | 5,000 | $48,125 |
| 2010-02 | 0 | $0 | 0 | $0 | 72,606 | $1,036,886 |
| 2009-09 | 0 | $0 | 3,853,880 | $54,287,588 | 0 | $0 |
| 2009-02 | 0 | $0 | 0 | $0 | 16,344 | $12,764 |
| 2008-08 | 0 | $0 | 10,309,375 | $217,453,877 | 100 | $1,654 |
| 2008-06 | 261,207 | $7,815,313 | 0 | $0 | 0 | $0 |
| 2008-05 | 416,619 | $11,623,670 | 40,000 | $1,280,090 | 0 | $0 |
| 2008-04 | 4,502,240 | $131,997,310 | 60,000 | $1,925,620 | 0 | $0 |
| 2008-03 | 459,881 | $12,639,294 | 0 | $0 | 5,608 | $13,711 |
| 2008-02 | 75,000 | $2,014,300 | 8,308 | $254,047 | 76,724 | $326,259 |
| 2008-01 | 0 | $0 | 40,100 | $1,408,331 | 14,700 | $105,497 |
| 2007-12 | 0 | $0 | 41,100 | $1,551,648 | 22,700 | $148,395 |
| 2007-11 | 0 | $0 | 44,600 | $1,838,190 | 96,645 | $443,628 |
| 2007-10 | 0 | $0 | 51,800 | $2,510,251 | 20,700 | $214,490 |
| 2007-09 | 0 | $0 | 56,100 | $2,744,786 | 30,150 | $303,238 |
| 2007-08 | 0 | $0 | 109,914 | $5,427,298 | 73,700 | $858,126 |
| 2007-07 | 0 | $0 | 50,892 | $2,188,094 | 163,200 | $582,607 |
| 2007-06 | 0 | $0 | 53,892 | $2,406,633 | 39,098 | $486,521 |
| 2007-05 | 0 | $0 | 84,618 | $3,679,999 | 49,200 | $571,623 |
| 2007-04 | 0 | $0 | 54,738 | $2,196,776 | 20,700 | $118,979 |
| 2007-03 | 0 | $0 | 41,892 | $1,573,307 | 50,969 | $482,549 |
| 2007-02 | 0 | $0 | 27,892 | $1,107,171 | 16,700 | $140,907 |
| 2007-01 | 0 | $0 | 25,192 | $990,690 | 133,479 | $409,497 |
| 2006-12 | 0 | $0 | 32,692 | $1,254,682 | 29,673 | $354,844 |
| 2006-11 | 0 | $0 | 68,192 | $2,963,196 | 17,500 | $142,856 |
| 2006-10 | 0 | $0 | 62,038 | $2,752,057 | 17,500 | $163,626 |
| 2006-09 | 0 | $0 | 62,525 | $2,849,235 | 18,500 | $173,175 |
| 2006-08 | 0 | $0 | 79,038 | $3,498,594 | 21,593 | $175,972 |
| 2006-07 | 0 | $0 | 61,038 | $2,974,139 | 8,500 | $91,454 |
| 2006-06 | 0 | $0 | 30,846 | $1,417,078 | 18,869 | $286,120 |
| 2006-05 | 0 | $0 | 66,384 | $2,842,093 | 18,000 | $76,945 |
| 2006-04 | 0 | $0 | 59,692 | $2,758,785 | 23,000 | $121,569 |
| 2006-03 | 0 | $0 | 58,192 | $2,587,719 | 19,500 | $81,126 |
| 2006-02 | 0 | $0 | 97,846 | $3,951,179 | 54,154 | $72,276 |
| 2006-01 | 0 | $0 | 65,121 | $2,735,444 | 100,555 | $1,086,930 |
| 2005-12 | 0 | $0 | 39,940 | $1,543,914 | 3,500 | $19,565 |
| 2005-11 | 0 | $0 | 39,692 | $1,420,951 | 0 | $0 |
| 2005-10 | 0 | $0 | 34,692 | $1,215,665 | 0 | $0 |
| 2005-09 | 0 | $0 | 34,692 | $1,112,681 | 0 | $0 |
| 2005-08 | 0 | $0 | 13,538 | $317,177 | 0 | $0 |
| 2005-07 | 0 | $0 | 9,192 | $196,042 | 0 | $0 |
| 2005-06 | 0 | $0 | 31,692 | $604,387 | 0 | $0 |
| 2005-05 | 50,000 | $841,341 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-04-18 | Cook Joseph C Jr (Director) | Sale | 10,000 | 41.94 | 419,370 |
| 2007-04-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 40.58 | 271,859 |
| 2007-04-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | .55 | 3,664 |
| 2007-04-16 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 40.55 | 40,550 |
| 2007-04-16 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 5.73 | 5,730 |
| 2007-04-16 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.46 | 159,443 |
| 2007-04-13 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 40.06 | 200,300 |
| 2007-04-13 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 2.91 | 14,530 |
| 2007-04-13 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 40.06 | 40,060 |
| 2007-04-13 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 5.73 | 5,730 |
| 2007-04-09 | Bradbury Daniel (President & Chief Exec Officer) | Sale | 2,500 | 38.66 | 96,655 |
| 2007-04-04 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.94 | 379,440 |
| 2007-04-02 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 37.47 | 18,735 |
| 2007-04-02 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-04-02 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 36.95 | 73,900 |
| 2007-04-02 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-04-02 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.12 | 142,775 |
| 2007-03-30 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 37.61 | 94,025 |
| 2007-03-30 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 13.25 | 33,125 |
| 2007-03-22 | Bradbury Daniel (President & Chief Operating) | Option Ex | 39,269 | 10.49 | 411,892 |
| 2007-03-19 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.71 | 377,140 |
| 2007-03-19 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.71 | 145,048 |
| 2007-03-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 38.20 | 255,926 |
| 2007-03-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | .78 | 5,232 |
| 2007-03-07 | Bradbury Daniel (President & Chief Operating) | Sale | 2,500 | 37.00 | 92,500 |
| 2007-03-05 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.20 | 371,950 |
| 2007-03-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 37.20 | 143,071 |
| 2007-03-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 37.75 | 18,875 |
| 2007-03-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 37.39 | 74,772 |
| 2007-03-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-02-28 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 38.82 | 97,050 |
| 2007-02-28 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 12.60 | 31,500 |
| 2007-02-20 | Greene Howard E Jr (Director) | Sale | 3,846 | 40.49 | 155,709 |
| 2007-02-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 40.23 | 269,547 |
| 2007-02-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | .78 | 5,232 |
| 2007-02-07 | Bradbury Daniel (President & Chief Operating) | Sale | 3,500 | 40.52 | 141,820 |
| 2007-02-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.63 | 152,405 |
| 2007-02-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 38.75 | 19,375 |
| 2007-02-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-02-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 38.92 | 77,840 |
| 2007-02-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-02-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 38.69 | 193,425 |
| 2007-02-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 14.38 | 71,875 |
| 2007-01-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 39.00 | 97,500 |
| 2007-01-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 11.95 | 29,875 |
| 2007-01-22 | Greene Howard E Jr (Director) | Sale | 3,846 | 39.55 | 152,101 |
| 2007-01-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.54 | 207,710 |
| 2007-01-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | .78 | 3,905 |
| 2007-01-11 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 40.00 | 200,000 |
| 2007-01-11 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 3.28 | 16,405 |
| 2007-01-09 | Bradbury Daniel (President & Chief Operating) | Sale | 2,500 | 38.51 | 96,275 |
| 2007-01-08 | Greene Howard E Jr (Director) | Sale | 3,846 | 38.16 | 146,759 |
| 2007-01-03 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 36.29 | 18,145 |
| 2007-01-03 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-01-03 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 36.10 | 72,200 |
| 2007-01-03 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 5,000 | 8.84 | 44,200 |
| 2007-01-02 | Cook Joseph C Jr (Director) | Option Ex | 115,479 | 2.66 | 306,712 |
| 2006-12-29 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 35.89 | 89,725 |
| 2006-12-29 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 11.95 | 29,875 |
| 2006-12-26 | Greene Howard E Jr (Director) | Sale | 3,846 | 36.79 | 141,509 |
| 2006-12-14 | Cook Joseph C Jr (Director) | Sale | 10,000 | 37.90 | 378,970 |
| 2006-12-14 | Cook Joseph C Jr (Director) | Option Ex | 15,000 | 13.62 | 204,375 |
| 2006-12-11 | Greene Howard E Jr (Director) | Sale | 3,846 | 38.44 | 147,821 |
| 2006-12-07 | Bradbury Daniel (President & Chief Operating) | Sale | 2,500 | 39.35 | 98,367 |
| 2006-12-05 | Graham Ginger L (Chief Executive Officer) | Option Ex | 2,173 | 23.00 | 49,979 |
| 2006-12-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 39.39 | 78,780 |
| 2006-12-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 11.95 | 23,900 |
| 2006-12-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 40.03 | 200,150 |
| 2006-12-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 3.28 | 16,405 |
| 2006-12-01 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 39.34 | 39,340 |
| 2006-12-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2006-12-01 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 40.01 | 80,020 |
| 2006-12-01 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-11-30 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 40.76 | 101,900 |
| 2006-11-30 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 11.54 | 28,842 |
| 2006-11-28 | Cook Joseph C Jr (Director) | Sale | 10,000 | 41.32 | 413,180 |
| 2006-11-27 | Greene Howard E Jr (Director) | Sale | 3,846 | 40.77 | 156,816 |
| 2006-11-15 | Stetsko Gregg (VP Operations) | Sale | 3,000 | 44.92 | 134,760 |
| 2006-11-15 | Stetsko Gregg (VP Operations) | Option Ex | 3,000 | 5.73 | 17,190 |
| 2006-11-13 | Cook Joseph C Jr (Director) | Sale | 10,000 | 44.77 | 447,720 |
| 2006-11-13 | Greene Howard E Jr (Director) | Sale | 3,846 | 44.77 | 172,204 |
| 2006-11-07 | Bradbury Daniel (President & Chief Operating) | Sale | 3,000 | 44.51 | 133,536 |
| 2006-11-07 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 45.00 | 90,000 |
| 2006-11-07 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 8.43 | 16,854 |
| 2006-11-03 | Cook Joseph C Jr (Director) | Sale | 10,000 | 43.40 | 433,960 |
| 2006-11-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 44.01 | 88,020 |
| 2006-11-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-11-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 44.02 | 220,100 |
| 2006-11-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 7.64 | 38,200 |
| 2006-11-01 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 44.01 | 44,010 |
| 2006-11-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2006-11-01 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 44.02 | 88,040 |
| 2006-11-01 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-11-01 | Greene Howard E Jr (Director) | Sale | 10,000 | 43.90 | 438,950 |
| 2006-10-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 43.91 | 109,774 |
| 2006-10-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 11.12 | 27,812 |
| 2006-10-30 | Greene Howard E Jr (Director) | Sale | 3,846 | 44.15 | 169,800 |
| 2006-10-19 | Cook Joseph C Jr (Director) | Sale | 10,000 | 46.47 | 464,730 |
| 2006-10-16 | Stetsko Gregg (VP Operations) | Sale | 3,000 | 46.80 | 140,400 |
| 2006-10-16 | Stetsko Gregg (VP Operations) | Option Ex | 3,000 | 5.73 | 17,190 |
| 2006-10-16 | Greene Howard E Jr (Director) | Sale | 3,846 | 47.08 | 181,058 |
| 2006-10-09 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 45.00 | 90,000 |
| 2006-10-09 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 8.43 | 16,854 |
| 2006-10-06 | Bradbury Daniel (President & Chief Operating) | Sale | 3,000 | 42.50 | 127,500 |
| 2006-10-05 | Cook Joseph C Jr (Director) | Sale | 10,000 | 43.65 | 436,460 |
| 2006-10-02 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 43.07 | 86,146 |
| 2006-10-02 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-10-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 43.57 | 217,845 |
| 2006-10-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 12.00 | 60,000 |
| 2006-10-02 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 43.07 | 43,073 |
| 2006-10-02 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2006-10-02 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.67 | 87,346 |
| 2006-10-02 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 5.73 | 11,460 |
| 2006-10-02 | Greene Howard E Jr (Director) | Sale | 13,846 | 43.18 | 597,925 |
| 2006-09-21 | Cook Joseph C Jr (Director) | Sale | 10,000 | 45.50 | 454,960 |
| 2006-09-18 | Greene Howard E Jr (Director) | Sale | 3,846 | 45.10 | 173,458 |
| 2006-09-15 | Stetsko Gregg (VP Operations) | Sale | 3,000 | 44.32 | 132,951 |
| 2006-09-15 | Stetsko Gregg (VP Operations) | Option Ex | 3,000 | 5.73 | 17,190 |
| 2006-09-15 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,000 | 44.35 | 88,700 |
| 2006-09-15 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,000 | 10.50 | 21,000 |
| 2006-09-08 | Bradbury Daniel (Chief Operating Officer) | Sale | 4,222 | 44.25 | 186,822 |
| 2006-09-06 | Cook Joseph C Jr (Director) | Sale | 10,000 | 46.06 | 460,570 |
| 2006-09-05 | Greene Howard E Jr (Director) | Sale | 3,846 | 46.48 | 178,773 |
| 2006-09-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 45.21 | 90,420 |
| 2006-09-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.66 | 11,320 |
| 2006-09-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 46.14 | 230,685 |
| 2006-09-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 12.00 | 60,000 |
| 2006-09-01 | Eberhard Craig A (VP Sales) | Sale | 1,500 | 45.21 | 67,815 |
| 2006-09-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,500 | 18.85 | 28,275 |
| 2006-09-01 | Baron Alain D (Sr VP Research) | Sale | 5,000 | 45.94 | 229,700 |
| 2006-09-01 | Baron Alain D (Sr VP Research) | Option Ex | 5,000 | 7.08 | 35,390 |
| 2006-09-01 | Greene Howard E Jr (Director) | Sale | 10,000 | 46.10 | 460,970 |
| 2006-08-28 | Greene Howard E Jr (Director) | Sale | 3,846 | 45.96 | 176,766 |
| 2006-08-25 | Cook Joseph C Jr (Director) | Sale | 10,000 | 45.33 | 453,320 |
| 2006-08-21 | Greene Howard E Jr (Director) | Sale | 3,846 | 46.11 | 177,323 |
| 2006-08-15 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,000 | 41.76 | 83,520 |
| 2006-08-15 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,000 | 9.88 | 19,750 |
| 2006-08-14 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.56 | 159,847 |
| 2006-08-11 | Cook Joseph C Jr (Director) | Sale | 20,000 | 41.18 | 823,560 |
| 2006-08-07 | Bradbury Daniel (Chief Operating Officer) | Sale | 3,000 | 47.41 | 142,230 |
| 2006-08-07 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 46.93 | 234,640 |
| 2006-08-07 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 12,093 | 7.64 | 92,390 |
| 2006-08-07 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 47.41 | 47,410 |
| 2006-08-07 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2006-08-01 | Rowland Lloyd A (VP Legal & General Counsel) | Sale | 2,000 | 47.43 | 94,862 |
| 2006-08-01 | Rowland Lloyd A (VP Legal & General Counsel) | Option Ex | 2,000 | 5.59 | 11,180 |
| 2006-08-01 | Eberhard Craig A (VP Sales) | Sale | 1,500 | 47.42 | 71,136 |
| 2006-08-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,500 | 18.85 | 28,275 |
| 2006-08-01 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 48.28 | 144,840 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.